吞咽电刺激治疗
康复理疗
≈ ¥200-500
(≈ $30-70)
大约20-40分钟
免责声明：本站为医疗服务机构，页面信息部分由AI协助制作。健康相关信息不构成医疗建议。如有任何疑问，请咨询医疗专业人士。详情见免责声明
项目介绍
吞咽电刺激治疗在一般公立医院参考费用约¥140-400，三甲医院参考费用约¥200-500，常用于相关诊断评估与就医安排，费用随医院及地区有所差异。
主要用途
Primary clinical uses include: 1) Neurorehabilitation for dysphagia secondary to stroke, traumatic brain injury, or neurodegenerative disorders; 2) Enhancing cortical and brainstem excitability to promote neural plasticity in the swallowing network; 3) Improving hyolaryngeal excursion, pharyngeal contraction, and upper esophageal sphincter relaxation; 4) Adjunctive therapy combined with traditional swallowing exercises (e.g., effortful swallow, Mendelsohn maneuver); 5) Early intervention in acute/subacute phases to prevent dysphagia chronicity and reduce pneumonia risk.
正常值范围
Swallowing electrical stimulation (e-stim) therapy is not a diagnostic test with quantitative 'values' or numerical reference ranges; it is a neuromuscular rehabilitation intervention. Therefore, there is no standardized 'normal range' of measurable biomarkers or numerical outputs. Clinical parameters such as stimulation intensity (typically 10–30 mA), pulse duration (200–700 µs), frequency (30–80 Hz), and treatment duration (20–30 minutes/session, 5–10 sessions/week) are protocol-dependent and individualized based on patient tolerance and therapeutic goals—not population-based reference values.
偏低可能原因
Low stimulation response or suboptimal outcomes may result from: 1) Severe neurodegeneration (e.g., advanced Parkinson’s disease or ALS), 2) Complete denervation of pharyngeal muscles, 3) Poor electrode placement or inadequate skin contact, 4) Inadequate patient cooperation or cognitive impairment limiting volitional swallow effort during stimulation, 5) Concurrent severe structural obstruction (e.g., post-radiation fibrosis or large tumor mass).
偏高可能原因
Excessive or adverse responses to swallowing e-stim may arise from: 1) Overly high stimulation intensity causing laryngospasm or airway compromise, 2) Stimulation applied during active aspiration (increasing aspiration risk), 3) Use in patients with active upper aerodigestive tract infection or acute inflammation, 4) Contraindicated application over implanted electronic devices (e.g., pacemakers, vagus nerve stimulators), 5) Unsupervised home use without clinician titration leading to muscle fatigue or discomfort.